Post Tagged with: "PTLA"

Active Movers: Kinross Gold Corporation (NYSE:KGC), Portola Pharmaceuticals (NASDAQ:PTLA), Brookfield Asset Management Inc. (NYSE:BAM), Optibase (NASDAQ:OBAS), Freeport-McMoRan Inc. (NYSE:FCX)

December 22, 2014 at 1:21 pm 0 comments

Kinross Gold Corporation (NYSE:KGC) Director John A. Brough bought 8,600 shares of the company’s stock on the open market in a transaction that occurred on Friday, December 12th. The stock was purchased at an average cost of $3.48 per share,Read More

Traders Should Watch: Pfizer Inc. (NYSE:PFE), Facebook Inc (NASDAQ:FB), Central Pacific Financial Corp. (NYSE:CPF), Portola Pharmaceuticals (NASDAQ:PTLA), Ameren Corporation (NYSE:AEE)

December 21, 2014 at 3:39 pm 0 comments

Pfizer Inc. (NYSE:PFE) announced positive results for its Phase III study evaluating pregabalin controlled-release (CR) treatment, marketed as Lyrica, as a treatment for postherpetic neuralgia, or pain due to nerve damage. Pfizer Inc. (NYSE:PFE) in last trading activity fell -0.09%Read More

Mix Sector Stocks: Williams Companies (NYSE:WMB), Hertz Global Holdings (NYSE:HTZ), Education Management Corporation (NASDAQ:EDMC), Outerwall Inc. (NASDAQ:OUTR), Portola Pharmaceuticals (NASDAQ:PTLA)

December 19, 2014 at 12:51 pm 0 comments

Williams Companies, Inc. (NYSE:WMB) board of directors has approved a regular dividend of $0.57 on the company’s common stock, payable December 29 to holders of record at the close of business December 12. The new amount is an increase ofRead More

Top News: Staples (NASDAQ:SPLS), Whiting Petroleum Corp. (NYSE:WLL), Portola Pharmaceuticals (NASDAQ:PTLA), The Toronto-Dominion Bank (NYSE:TD), China Digital TV Holding (NYSE:STV)

December 12, 2014 at 1:33 pm 0 comments

HP (NYSE: HPQ) on Dec. 8 announced its alliance with Staples, Inc. (NASDAQ: SPLS), the world’s largest office products company and one of the biggest internet retailers, with Staples becoming the newest US retailer to offer HP Instant Ink replacementRead More

Don’t Miss: China Mobile Limited (NYSE:CHL), Sprint Corporation (NYSE:S), Delta Apparel Inc. (NYSEMKT:DLA), Portola Pharmaceuticals (NASDAQ:PTLA), Celldex Therapeutics (NASDAQ:CLDX)

December 1, 2014 at 1:17 pm 0 comments

China Mobile Limited (NYSE:CHL) was upgraded by equities research analysts at BNP Paribas from a “hold” rating to a “buy” rating in a research note issued to investors on Monday. China Mobile Limited (NYSE:CHL) in last trading activity moved downRead More

Today’s Watch List: Portola Pharmaceuticals (NASDAQ:PTLA), Baxano Surgical (NASDAQ:BAXS), Buffalo Wild Wings Inc. (NASDAQ:BWLD), Valeant Pharmaceuticals (NYSE:VRX), AGCO Corporation (NYSE:AGCO)

November 14, 2014 at 2:43 pm 0 comments

On 10 November Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) issued its quarterly earnings data on Monday. The company reported ($0.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.92) by $0.06. The company had revenue of $2.40 millionRead More

Top News: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Ford Motor Company (NYSE:F), Silver Wheaton Corp. (NYSE:SLW), Comtech Telecommunications Corp. (NASDAQ:CMTL), Portola Pharmaceuticals (NASDAQ:PTLA)

November 14, 2014 at 2:37 pm 0 comments

On 6 November Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) announced its financial results for the third quarter ended September 30, 2014. The net loss for the third quarter ended September 30, 2014 was $35.3 million, or $0.38 per share, compared to aRead More

Shining on Major News: Eldorado Gold Corp. (NYSE:EGO), CBS Corporation (NYSE:CBS), Wells Fargo & Company (NYSE:WFC), Multi-Fineline Electronix (NASDAQ:MFLX), Portola Pharmaceuticals (NASDAQ:PTLA)

November 7, 2014 at 12:18 pm 0 comments

On 30 October Eldorado Gold Corp. (NYSE:EGO) reported the Company’s financial and operational results for the third quarter ended September 30, 2014. During the quarter, the Company generated $263.5 million in revenues from metal sales, and adjusted net earnings ofRead More

Moving Stocks: Portola Pharmaceuticals (NASDAQ:PTLA), Groupon (NASDAQ:GRPN), Microsoft Corporation (NASDAQ:MSFT), The Ultimate Software Group (NASDAQ:ULTI), Spectra Energy Partners (NYSE:SEP)

November 6, 2014 at 1:26 pm 0 comments

Portola Pharmaceuticals (NASDAQ:PTLA) will post its Q314 quarterly earnings results on Monday, November 10th. Analysts expect Portola Pharmaceuticals to post earnings of ($0.92) per share and revenue of $2.73 million for the quarter. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) in last tradingRead More